Prelude Therapeutics Incorporated (PRLD) SEC filings
PRLD SEC filings moved a median of -1.35% by the close. PRLD SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the PRLD overview →
68 measured PRLD SEC filing events.
Where these PRLD SEC filings landedvs 68 measured PRLD SEC filing reactions
| Middle 50% of PRLD SEC filing reactions | -6.11% to +6.76% |
|---|---|
| Median reaction (to close) | -1.35% |
| Measured reactions | 68 |
Point-in-time · zero look-ahead
Half of the 68 PRLD SEC filing events with a measured close landed between -6.11% and +6.76%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Prelude Therapeutics For: Sep 10 | SEC filing · Form 8-K | -1.79% | -7.34% | |
| Form 10-Q Prelude Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -0.91% | +7.47% | |
| Form 8-K Prelude Therapeutics For: Aug 11 | SEC filing · Form 8-K | -0.91% | +7.47% | |
| Form 8-K Prelude Therapeutics For: Jun 09 | SEC filing · Form 8-K | -1.01% | +4.05% | |
| Form 10-Q Prelude Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -1.04% | -3.33% | |
| Form 8-K Prelude Therapeutics For: May 12 | SEC filing · Form 8-K | -1.04% | -3.33% | |
| Form ARS Prelude Therapeutics For: Dec 31 | SEC filing · Form ARS | -4.42% | +15.71% | |
| Form DEF 14A Prelude Therapeutics For: Jun 09 | SEC filing · Form DEF | -4.42% | +15.71% | |
| Form DEFA14A Prelude Therapeutics | SEC filing · Form DEFA14A | -4.42% | +15.71% | |
| Form 8-K Prelude Therapeutics For: Apr 20 | SEC filing · Form 8-K | -4.05% | -1.49% | |
| Form 8-K Prelude Therapeutics For: Apr 20 | SEC filing · Form 8-K | +1.20% | -9.80% | |
| Form 8-K Prelude Therapeutics For: Apr 15 | SEC filing · Form 8-K | +3.69% | +27.19% | |
| Form 8-K Prelude Therapeutics For: Mar 12 | SEC filing · Form 8-K | -1.49% | -1.49% | |
| Form 10-K Prelude Therapeutics For: Dec 31 | SEC filing · Form 10-K | +5.35% | +20.40% | |
| Form 8-K Prelude Therapeutics For: Mar 10 | SEC filing · Form 8-K | +5.35% | +20.40% | |
| Form S-8 Prelude Therapeutics | SEC filing · Form S-8 | +5.35% | +20.40% | |
| Form 8-K Prelude Therapeutics For: Jan 29 | SEC filing · Form 8-K | +6.34% | +11.71% | |
| Form 8-K Prelude Therapeutics For: Jan 09 | SEC filing · Form 8-K | -1.08% | -5.40% | |
| Form EFFECT Prelude Therapeutics | SEC filing · Form EFFECT | -1.97% | -3.94% | |
| Form S-3 Prelude Therapeutics | SEC filing · Form S-3 | +0.91% | -1.21% | |
| Form 10-Q Prelude Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -0.72% | +6.52% | |
| Form 8-K Prelude Therapeutics For: Nov 12 | SEC filing · Form 8-K | -0.72% | +6.52% | |
| Form 8-K Prelude Therapeutics For: Nov 03 | SEC filing · Form 8-K | -5.66% | -16.98% | |
| Form 8-K Prelude Therapeutics For: Oct 15 | SEC filing · Form 8-K | +0.00% | -8.46% | |
| Form 8-K Prelude Therapeutics For: Sep 18 | SEC filing · Form 8-K | +3.96% | -2.50% | |
| Form 10-Q Prelude Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -2.98% | +4.19% | |
| Form 8-K Prelude Therapeutics For: Aug 14 | SEC filing · Form 8-K | -2.98% | +4.19% | |
| Form 8-K Prelude Therapeutics For: Jun 11 | SEC filing · Form 8-K | +0.00% | -2.61% | |
| Form 10-Q Prelude Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -6.45% | |
| Form 8-K Prelude Therapeutics For: May 06 | SEC filing · Form 8-K | +0.00% | -6.45% | |
| Form ARS Prelude Therapeutics For: Dec 31 | SEC filing · Form ARS | +0.00% | +3.55% | |
| Form DEF 14A Prelude Therapeutics For: Jun 12 | SEC filing · Form DEF | +0.00% | +3.55% | |
| Form DEFA14A Prelude Therapeutics | SEC filing · Form DEFA14A | +0.00% | +3.55% | |
| Form 8-K Prelude Therapeutics For: Apr 25 | SEC filing · Form 8-K | +3.41% | +0.75% | |
| Form PRE 14A Prelude Therapeutics For: Jun 12 | SEC filing · Form PRE | -0.25% | -2.25% | |
| Form 8-K Prelude Therapeutics For: Mar 27 | SEC filing · Form 8-K | +1.46% | +0.16% | |
| Form 10-K Prelude Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.00% | -6.94% | |
| Form 8-K Prelude Therapeutics For: Mar 10 | SEC filing · Form 8-K | +0.00% | -6.94% | |
| Form S-8 Prelude Therapeutics | SEC filing · Form S-8 | +0.00% | -6.94% | |
| Form 8-K Prelude Therapeutics For: Feb 03 | SEC filing · Form 8-K | +1.29% | -5.13% | |
| Form 8-K Prelude Therapeutics For: Dec 11 | SEC filing · Form 8-K | -2.07% | -3.10% | |
| Form 10-Q Prelude Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -0.76% | -3.79% | |
| Form 8-K Prelude Therapeutics For: Nov 06 | SEC filing · Form 8-K | -0.76% | -3.79% | |
| Form 8-K Prelude Therapeutics For: Oct 24 | SEC filing · Form 8-K | -4.11% | -7.19% | |
| Form 8-K Prelude Therapeutics For: Sep 13 | SEC filing · Form 8-K | -3.96% | -6.47% | |
| Form 8-K Prelude Therapeutics For: Sep 09 | SEC filing · Form 8-K | +1.22% | +1.22% | |
| Form 10-Q Prelude Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -1.40% | -5.00% | |
| Form 8-K Prelude Therapeutics For: Aug 12 | SEC filing · Form 8-K | -1.40% | -5.00% | |
| Form 8-K Prelude Therapeutics For: Jun 14 | SEC filing · Form 8-K | +0.00% | -1.20% | |
| Form 8-K Prelude Therapeutics For: Jun 12 | SEC filing · Form 8-K | -3.82% | -3.82% | |
| Form EFFECT Prelude Therapeutics | SEC filing · Form EFFECT | +0.00% | +3.61% | |
| Form S-3 Prelude Therapeutics | SEC filing · Form S-3 | +0.00% | +0.26% | |
| Form 8-K/A Prelude Therapeutics For: Apr 08 | SEC filing · Form 8-K | +0.00% | -6.76% | |
| Form EFFECT Prelude Therapeutics | SEC filing · Form EFFECT | +2.21% | +12.43% | |
| Form 10-Q Prelude Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -7.50% | |
| Form 8-K Prelude Therapeutics For: May 07 | SEC filing · Form 8-K | +0.00% | -7.50% | |
| Form S-3/A Prelude Therapeutics | SEC filing · Form S-3 | +0.00% | -7.50% | |
| Form ARS Prelude Therapeutics For: Dec 31 | SEC filing · Form ARS | -1.71% | -6.11% | |
| Form DEF 14A Prelude Therapeutics For: Jun 14 | SEC filing · Form DEF | -1.71% | -6.11% | |
| Form DEFA14A Prelude Therapeutics | SEC filing · Form DEFA14A | -1.71% | -6.11% | |
| Form 8-K Prelude Therapeutics For: Apr 08 | SEC filing · Form 8-K | +0.00% | +5.67% | |
| Form S-3 Prelude Therapeutics | SEC filing · Form S-3 | +6.00% | +32.29% | |
| Form S-8 Prelude Therapeutics | SEC filing · Form S-8 | +6.00% | +32.29% | |
| Form 10-K Prelude Therapeutics For: Dec 31 | SEC filing · Form 10-K | +6.00% | +32.29% | |
| Form 8-K Prelude Therapeutics For: Feb 15 | SEC filing · Form 8-K | +6.00% | +32.29% | |
| Form 8-K Prelude Therapeutics For: Dec 11 | SEC filing · Form 8-K | -0.90% | -0.90% | |
| Form 10-Q Prelude Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +6.90% | +27.01% | |
| Form 8-K Prelude Therapeutics For: Nov 01 | SEC filing · Form 8-K | +6.90% | +27.01% |
Keep exploring
More PRLD: earnings → · analyst actions → · PRLD overview →